ACG Wealth’s Zoetis ZTS Stock Holding History

ACG Wealth’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-596	Closed	-$102K	–	1047
2022 Q2	$102K	Buy	+596	New	+$103K	0.02%	331
2022 Q1	–	Sell	-855	Closed	-$209K	–	344
2021 Q4	$209K	Buy	+855	New	+$187K	0.03%	303

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACG Wealth's ZTS Position: Q3 2022 in Review

ACG Wealth sold out of Zoetis (ZTS) in Q3 2022, closing a stake of 596 shares — an estimated $102K sold.

ACG Wealth first reported a position in ZTS in Q4 2021 and held it in 2 quarters. The position peaked at $209K in Q4 2021. 1,508 funds tracked by Wall St. Rank hold ZTS as of Q3 2022.

ACG Wealth reported no remaining Zoetis position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 596 Zoetis shares in Q3 2022, an estimated $102K.
ACG Wealth first reported a position in Zoetis in Q4 2021 and held it in 2 quarters.
ACG Wealth's Zoetis position peaked at $209K in Q4 2021.
1,508 funds tracked by Wall St. Rank held Zoetis as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.